ALFA Filings
Every announcement, straight from the exchange
Every Rossari Biotech results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.
Rossari Biotech reported Q1 FY27 consolidated revenue of ₹697.2 crore, up 28% YoY. It also established a new 5,000 MTPA greenfield blending facility in Thailand.
Rossari Biotech announced its FY26 results, reporting 15% revenue growth to ₹2,396.40 Crore. Q4 FY26 revenue reached a record ₹684.9 Crore, up 18% YoY, while annual PAT rose 9% to ₹149.2 Crore. The company also commissioned 15,000 MTPA additional capacity at its Dahej facility and recommended a ₹0.50 per share dividend.